|Articles|June 15, 2016
LSK Global PS Expanding Use of Medidata Platform
LSK Global PS announces that it will expand its use of Medidata’s Clinical Trial Management Solution.
Advertisement
LSK Global PS announces that it will expand its use of Medidata’s Clinical Trial Management Solution. The Korean CRO aims to improve oversight into trial operations and streamline its site monitoring processes using this tool.
Read the full release here
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
eClinical Technology: Misconceptions, Challenges, and OpportunitiesSeptember 9th 2025
How Sponsors Can Modernize Tools to Support PhysiciansSeptember 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
2
AstraZeneca’s Tagrisso Shows Landmark Overall Survival Benefit in Non-Small Cell Lung Cancer
3
Phase III EMPOWER-Lung 3 Trial Confirms Five-Year Survival Benefit With Libtayo Plus Chemotherapy in NSCLC
4
Investigational OX40-Targetting T-Cell Therapy Shows Durable Efficacy Treating Atopic Dermatitis in Phase III Trial
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
